EventsMOL2NET'21, Conference on Molecular, Biomed., Comput. & Network Science and Engineering, 7th ed.
Published
with-doi10.3390/mol2net-07-12126 (registering DOI)
This submission belongs to the session 01. CHEMBIO.INFO-07: Cheminfo., Chemom., Comput. Chem. & Bioinfo. Congress München, GR-Cambridge, UK-Ch. Hill, USA, 2021. of the event MOL2NET'21, Conference on Molecular, Biomed., Comput. & Network Science and Engineering, 7th ed.
Published date
02 Jan, 2022
Academic Editor
author-avatarHumbert G. Díaz
Citation
André F. Pina, Sérgio F. Sousa, Nuno Cerqueira, A computational study on the catalytic mechanism of Pdx2: a glutaminase containing the Cys-His-Glu triad, in Proceedings of MOL2NET'21, Conference on Molecular, Biomed., Comput. & Network Science and Engineering, 7th ed., 25 January–30 December 2021, MDPI: Basel, Switzerland, doi: 10.3390/mol2net-07-12126
Share
Email
Facebook
Twitter
LinkedIn

A computational study on the catalytic mechanism of Pdx2: a glutaminase containing the Cys-His-Glu triad

image
image
image
1. Associate Laboratory i4HB – Institute for Health and Bioeconomy, Faculty of Medicine, University of Porto, 4200-319 Porto, Portugal, Portugal
2. UCIBIO – Applied Molecular Biosciences Unit, BioSIM – Department of Biomedicine, Faculty of Medicine, University of Porto, 4200-319 Porto, Portugal
3. Associate Laboratory i4HB – Institute for Health and Bioeconomy, Faculty of Medicine, University of Porto, 4200-319 Porto, Portugal
Abstract

Pdx2, the glutaminase subunit of the pyridoxal 5’-phosphate (PLP) synthase, is a key enzyme in the synthesis of PLP. It employs a non-canonical Cys-His-Glu triad to catalyze the deamination of glutamine to glutamate and ammonia – the source of the nitrogen of PLP. For this reason, Pdx2 is considered a novel and promising drug target against diseases such as Malaria and Tuberculosis, whose pathogens rely on this enzyme to obtain PLP. Therefore, the catalytic mechanism of Pdx2 was studied with atomic detail using the computational ONIOM QM/MM methodology with an 80/81 atoms QM region, which includes all catalytic relevant residues, treated at the DLPNO-CCSD(T)/CBS//B3LYP/6-31G(d,p):ff14SB level. The results demonstrate that the catalytic mechanism of Pdx2 occurs in six steps divided into four main stages: (i) activation of Cys87, (ii) deamination of glutamine with formation of the glutamyl-thioester intermediate, (iii) hydrolysis of the formed intermediate, and (iv) enzymatic turnover. The rate-limiting step of the complete catalytic mechanism is the hydrolysis of the glutamyl-thioester intermediate (18.2 kcal.mol-1), which closely agrees with the available kinetic data (19.1–19.5 kcal mol-1). The catalytic mechanism of Pdx2 differs from other known amidases in three main points: i) it requires the activation of the nucleophile Cys87 to a thiolate; ii) the hydrolysis occurs in a single step without formation of a second tetrahedral intermediate, and iii) Glu198 does not have a direct role in the catalytic process.

Keywords
catalytic triad
Cys-His-Glu
QM/MM
catalytic mechanism
Manuscript

NEURODAT'21 IBRO-PERC Lecture on Computational Neuroscience

Correlated NAAG metabolism imbalance with ‘attention switching/tolerance of change’: a biomarker in the actual triad of impairment in autism.